Literature DB >> 29993330

Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China.

Wenlong Wu1,2, Jingjing Lv1,2, Jiaye Liu1,2, Bingyu Yan1,2, Yi Feng1,2, Aiqiang Xu1,2, Li Zhang1,2.   

Abstract

Immune memory after hepatitis B vaccination among adults is still under investigation. In this study, adults who had normal and high antibody response to the primary series of hepatitis B vaccination (HepB) were followed up at 5 years after the primary immunization. A booster dose was given to those who had low hepatitis B surface antibody (anti-HBs) titers, defined as anti-HBs levels < 10 mIU/mL. Blood samples were collected at two weeks after the booster and anti-HBs levels were measured. We assumed those with ant-HBs levels > = 10 mIU/mL after the booster had anamnestic response. In total, 242 persons completed the booster and the anti-HBs test. The anamnestic response rate was 99.59% (241/242) and geometric mean concentration (GMC) of anti-HBs after the booster was 2989 mIU/mL (95% CI: 255, 35085). Anti-HBs titer after the booster dose had a positive correlation with anti-HBs titers measured right after the primary immunization as well as anti-HBs titers 5 years later just before the booster. After the booster, no significant difference was found in anti-HBs titers between participants who were immunized with the 10μg HepB vaccine and those with the 20μg vaccine. Multivariable analysis showed that 1) vaccine brand used for the primary vaccination, 2) anti-HBs titers after primary vaccination and 3) anti-HBs titers before the booster dose were independently associated with the anti-HBs titers after the booster 1) β = -0.21, 95% CI: -0.33, -0.09, P = 0.001; 2) β = 0.07, 95% CI: 0.05, 0.09, P < 0.001; 3) β = 0.04, 95% CI: 0.02, 0.07, P < 0.001). In summary, anamnestic response exists among almost all adults at five years after HepB primary immunization. Vaccine brand used for primary vaccination, initial anti-HBs titers after primary immunization and anti-HBs titers before the booster were the independent predictive factors of HepB anamnestic response titers.

Entities:  

Keywords:  Adults; Booster dose; Hepatitis B vaccine; Immune memory

Mesh:

Substances:

Year:  2018        PMID: 29993330      PMCID: PMC6284486          DOI: 10.1080/21645515.2018.1477911

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  36 in total

1.  [Technical guide for adult hepatitis B immunization in China].

Authors:  Fu-Qiang Cui
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2011-12

2.  Hepatitis B vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-10-01

3.  Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.

Authors:  Helen Marshall; Terry Nolan; Javier Díez Domingo; Lars Rombo; Etienne M Sokal; Josep Marès; Josep M Casanovas; Sherine Kuriyakose; Maarten Leyssen; Jeanne-Marie Jacquet
Journal:  Vaccine       Date:  2010-04-29       Impact factor: 3.641

4.  Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.

Authors:  Jiri Beran; Olivier Van Der Meeren; Maarten Leyssen; Priya D'silva
Journal:  Vaccine       Date:  2016-04-20       Impact factor: 3.641

5.  Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.

Authors:  A Katoonizadeh; M Sharafkhah; M R Ostovaneh; A Norouzi; N Khoshbakht; A Mohamadkhani; L Eslami; A Gharravi; A Shayanrad; M Khoshnia; S Esmaili; J George; H Poustchi; R Malekzadeh
Journal:  J Viral Hepat       Date:  2016-04-29       Impact factor: 3.728

6.  Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.

Authors:  Li Zhang; Jiaye Liu; Jingjing Lu; Bingyu Yan; Lizhi Song; Li Li; Fuqiang Cui; Guomin Zhang; Fuzhen Wang; Xiaofeng Liang; Aiqiang Xu
Journal:  Hum Vaccin Immunother       Date:  2015-08-07       Impact factor: 3.452

Review 7.  A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.

Authors:  Pierre Van Damme; Koen Van Herck
Journal:  Expert Rev Vaccines       Date:  2004-06       Impact factor: 5.217

8.  [Antibody persistence following primary vaccination with hepatitis B vaccine among normal and high-responder adults: a 5-year follow-up study].

Authors:  W L Wu; B Y Yan; J J Lyu; J Y Liu; Y Feng; S Y Chen; L B Zhou; X F Liang; F Q Cui; F Z Wang; G M Zhang; L Zhang; A Q Xu
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2016-06

9.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Authors:  Xiaofeng Liang; Shengli Bi; Weizhong Yang; Longde Wang; Gang Cui; Fuqiang Cui; Yong Zhang; Jianhua Liu; Xiaohong Gong; Yuansheng Chen; Fuzhen Wang; Hui Zheng; Feng Wang; Jing Guo; Zhiyuan Jia; Jingchen Ma; Huaqing Wang; Huiming Luo; Li Li; Shuigao Jin; Stephen C Hadler; Yu Wang
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

10.  Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.

Authors:  Pierre Van Damme; Anna Moiseeva; Igor Marichev; Anne-Diane Kervyn; Robert Booy; Sherine Kuriyakose; Andrew Brockway; Su-Peing Ng; Maarten Leyssen; Jeanne-Marie Jacquet
Journal:  BMC Infect Dis       Date:  2010-12-20       Impact factor: 3.090

View more
  3 in total

1.  Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults.

Authors:  Juan Li; Fanyue Meng; Jingshan Zheng; Qi Liang; Huayu Li; Jingxin Li; Li Zhang; Jianhui Gan; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

2.  HLA-DPB1 alleles in hepatitis B vaccine response: A meta-analysis.

Authors:  Guojin Ou; Xiaojuan Liu; Yongmei Jiang
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

3.  Persistence of Immunity in Adults after 1, 5 and 10 Years with Recombinant Hepatitis B Vaccine in Beijing in 2010-2020.

Authors:  Sijia Shen; Shen Ge; Zheng Zhang; Jianxin Ma; Yang Jiao; Qian Li; Yan Liang; Shuming Li
Journal:  Vaccines (Basel)       Date:  2022-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.